Furthermore, the subgroup analyses revealed a significant relationship between high LRRFIP1 expression and overall survival in pancreatic cancer patients with various clinical features, including patients with T3&T4 (Fig. 2C, log-rank p = 0.038), G1&G2 (Fig. 2D, log-rank p = 0.046), head of pancreas (Fig. 2G, log-rank p = 0.012), and history of diabetes (Fig. 2H, log-rank p = 0.034). Here, LRRFIP1 is linked to diabetes mellitus.